Sun Jae Park

Mr. Sun Jae Park

Seoul National University Hospital, Seoul, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Gut and Liver
Verified
Journal Article
Open access
PDF file
SJSeogsong Jeong
Seogsong Jeong
YOYun Hwan Oh
Yun Hwan Oh
SCSeulggie Choi
Seulggie Choi
JCJooyoung Chang
Jooyoung Chang
SKSung Min Kim
Sung Min Kim
SPSang Min Park
Sang Min Park
Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Sun Jae Park, Yoosun Cho, Joung Sik Son, Gyeongsil Lee, and Sang Min Park. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl220038

9 May 2023 in Journal of Infection and Public Health
Verified
Journal Article
Open access
MKMinseo Kim
Minseo Kim
SPSun Jae Park
Sun Jae Park
SCSeulggie Choi
Seulggie Choi
SJSeogsong Jeong
Seogsong Jeong
JCJooyoung Chang
Jooyoung Chang
SPSang Min Park
Sang Min Park
Although recent studies indicated that antibiotics may be a risk factor for lung cancer, further understanding is needed. We investigated the association of long-term antibiotic exposure with lung cancer risk. This population-based retrospective cohort study investigated 6,214,926 participants aged ≥ 40 years who underwent health screening examinations (2005-2006) from the Korean National Health Insurance Service database. The date of the final follow-up was December 31, 2019. Exposures were the cumulative days of antibiotics prescription and the number of antibiotics classes. The adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for lung cancer risk according to antibiotic use were assessed using multivariable Cox proportional hazards regression. Compared with the antibiotic non-user group, participants with ≥ 365 days of antibiotics prescribed had a significantly increased risk of lung cancer (aHR, 1.21; 95% CI, 1.16-1.26). Participants with ≥ 365 days of antibiotics prescribed also had a significantly increased risk of lung cancer (aHR, 1.21; 95% CI, 1.17-1.24) than 1-14 days of the antibiotic user group. The results were also consistent in competing risk analyses and adjusted Cox regression models that fitted restricted cubic spline. Compared with the antibiotic non-user group, ≥ 5 antibiotic classes prescribed group had a higher lung cancer risk (aHR, 1.15; 95% CI, 1.10-1.21). The long-term cumulative days of antibiotic use and the increasing number of antibiotics classes were associated with an increased risk of lung cancer in a clear duration-dependent manner after adjusting for various risk factors.

Verified
Journal Article
Open access
PDF file
SKSoungmun Kim
Soungmun Kim
SJSeogsong Jeong
Seogsong Jeong
SPSun Jae Park
Sun Jae Park
JCJooyoung Chang
Jooyoung Chang
SCSeulggie Choi
Seulggie Choi
SPSang Min Park
Sang Min Park
(1) Background: The association between proton pump inhibitor (PPI) use and hepatocellular carcinoma (HCC) has been controversial, especially in the general population. We aimed to determine the impact of PPI on HCC risk in participants without liver cirrhosis or chronic hepatitis virus infection. (2) Methods: We assessed 406,057 participants from the Korean National Health Insurance Service database who underwent health screening from 2003 to 2006. We evaluated exposure to PPI before the index date using a standardized daily defined dose (DDD) system. The association of proton pump inhibitor use with the risk of HCC was evaluated using multivariable-adjusted Cox proportional hazards regression. (3) Results: Compared with non-users, PPI use was not associated with the HCC risk in low (<30 DDDs; aHR, 1.07; 95% CI, 0.91–1.27), intermediate (30 ≤ PPI < 60 DDDs; aHR, 0.96; 95% CI, 0.73–1.26), and high (≥60 DDDs; aHR, 0.86; 95% CI, 0.63–1.17) PPI groups in the final adjustment model. In addition, risks of cirrhosis-associated HCC and non-cirrhosis-associated HCC were not significantly associated with PPI use. The results remained consistent after excluding events that occurred within 1, 2, and 3 years to exclude pre-existing conditions that may be associated with the development of HCC. We also found no PPI-associated increase in HCC risk among the selected population, such as those with obesity, older age, and chronic liver diseases. (4) Conclusions: PPI use may not be associated with HCC risk regardless of the amount. We call for future studies conducted in other regions to generalize our findings.

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YLYohwan Lim
Yohwan Lim
HKHye Jun Kim
Hye Jun Kim
SYSung Soo Yoon
Sung Soo Yoon
SLSang Jun Lee
Sang Jun Lee
MLMyeong Hoon Lee
Myeong Hoon Lee
HHHyun Wook Han
Hyun Wook Han
Lim Y, et al. J Korean Med Sci. 2023 May;38(23):e176. https://doi.org/10.3346/jkms.2023.38.e176

Verified
Journal Article
Open access
PDF file
SLSang-Jun Lee
Sang-Jun Lee
SYSung Soo Yoon
Sung Soo Yoon
MLMyeong-Hoon Lee
Myeong-Hoon Lee
HKHye-Jun Kim
Hye-Jun Kim
YLYohwan Lim
Yohwan Lim
HHHyun Wook Han
Hyun Wook Han
Chronic obstructive pulmonary disease (COPD) is considered a major cause of death worldwide, and various studies have been conducted for its early diagnosis. Our work developed a scoring system by predicting and validating COPD and performed predictive model implementations. Participants who underwent a health screening between 2017 and 2020 were extracted from the Korea National Health and Nutrition Examination Survey (KNHANES) database. COPD individuals were defined as aged 40 years or older with prebronchodilator forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC < 0.7). The logistic regression model was performed, and the C-index was used for variable selection. Receiver operating characteristic (ROC) curves with area under the curve (AUC) values were generated for evaluation. Age, sex, waist circumference and diastolic blood pressure were used to predict COPD and to develop a COPD score based on a multivariable model. A simplified model for COPD was validated with an AUC value of 0.780 from the ROC curves. In addition, we evaluated the association of the derived score with cardiovascular disease (CVD). COPD scores showed significant performance in COPD prediction. The developed score also showed a good effect on the diagnostic ability for CVD risk. In the future, studies comparing the diagnostic accuracy of the derived scores with standard diagnostic tests are needed.

24 February 2023 in Tobacco Induced Diseases
Verified
Journal Article
Open access
MHMinjung Han
Minjung Han
SJSeogsong Jeong
Seogsong Jeong
JSJihun Song
Jihun Song
SPSun Jae Park
Sun Jae Park
CLCheol Min Lee
Cheol Min Lee
SPSang Min Park
Sang Min Park
Introduction: This study investigated the association between smoking types, including dual use (usage of both combustible cigarettes and e-cigarettes), and non-alcoholic fatty liver disease (NAFLD) status in Korean men. Methods: Data from the 7th and 8th Korea National Health and Nutrition...